BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 570205)

  • 1. Inhibition of complement-mediated lysis of sheep erythrocytes by cell-free preparations from Streptococcus mutans BHT.
    Silvestri LJ; Knox KW; Wicken AJ; Hoffmann EM
    J Immunol; 1979 Jan; 122(1):54-60. PubMed ID: 570205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RNA as a complement inhibitory component in an extract of Ehrlich ascites tumor cells.
    Renk CM; Hoffmann EM
    J Immunol; 1977 Jul; 119(1):263-70. PubMed ID: 326959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological properties of cellular and extracellular glycerol teichoic acid antigens of Streptococcus mutans.
    Hamada S; Mizuno J; Kotani S
    Microbios; 1979; 25(101-102):155-66. PubMed ID: 120923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M; Thesen R
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concanavalin A on the classical complement pathway.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of lipoteichoic acids by using phosphatidyl choline vesicles.
    Silvestri LJ; Craig RA; Ingram LO; Hoffmann EM; Bleiweis AS
    Infect Immun; 1978 Oct; 22(1):107-18. PubMed ID: 730344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G; Opferkuch W
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R; Erdtmann K
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.
    Hummell DS; Swift AJ; Tomasz A; Winkelstein JA
    Infect Immun; 1985 Feb; 47(2):384-7. PubMed ID: 3881346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of cross-reacting antibodies against cellular and extracellular lipoteichoic acid of Streptococcus mutans BHT.
    Knox KW; Markham JL; Wicken AJ
    Infect Immun; 1976 Mar; 13(3):647-52. PubMed ID: 1270127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monoclonal antibodies against lipoteichoic acid from the oral bacterium Streptococcus mutans on its adhesion and plaque-accumulation in vitro.
    Stashenko P; Peros WJ; Gibbons RJ; Dearborn SM
    Arch Oral Biol; 1986; 31(7):455-61. PubMed ID: 3467668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.